Neo Medical closes Swisscom Ventures-lead USD $20.6M financing round

Neo-Medical

Proceeds to accelerate the commercial deployment of Neo Medical AI-driven ADVISE™ augmented reality platform for spinal surgery

LAUSANNE, Switzerland, Feb. 17, 2022 /PRNewswire/ — Neo Medical, a Swiss-based medtech company developing value-based care solutions in spinal surgery, announced today the closing of a USD $20.6M financing round. The last round features Swisscom Ventures as lead investor, a testament to the expansion of the company’s spinal surgery integrated ecosystem in the digital space. In particular, the proceeds of this financing round will support the accelerated commercial deployment of Neo Medical ADVISE™ augmented reality platform for spinal surgery, with a particular focus on the US market.

Speaking about the closing of the USD $20.6M round, Vincent Lefauconnier, Neo Medical CEO, explained: “Over the past years, we have pushed our integrated physical platform for spinal surgery to levels never reached before, improving surgical outcomes, streamlining treatment cycles, and reducing environmental impacts, while lowering healthcare costs. Looking forward, we will focus on the commercial deployment of the digital component of our platform with ADVISE™, which for the first time bring surgeons real-time augmented reality (AR) visibility for patient specific spinal treatment.”